Cargando…

Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice

AIMS: Gp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2...

Descripción completa

Detalles Bibliográficos
Autores principales: Mighiu, Alexandra S, Recalde, Alice, Ziberna, Klemen, Carnicer, Ricardo, Tomek, Jakub, Bub, Gil, Brewer, Alison C, Verheule, Sander, Shah, Ajay M, Simon, Jillian N, Casadei, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479801/
https://www.ncbi.nlm.nih.gov/pubmed/33483749
http://dx.doi.org/10.1093/cvr/cvab019
_version_ 1784576336986112000
author Mighiu, Alexandra S
Recalde, Alice
Ziberna, Klemen
Carnicer, Ricardo
Tomek, Jakub
Bub, Gil
Brewer, Alison C
Verheule, Sander
Shah, Ajay M
Simon, Jillian N
Casadei, Barbara
author_facet Mighiu, Alexandra S
Recalde, Alice
Ziberna, Klemen
Carnicer, Ricardo
Tomek, Jakub
Bub, Gil
Brewer, Alison C
Verheule, Sander
Shah, Ajay M
Simon, Jillian N
Casadei, Barbara
author_sort Mighiu, Alexandra S
collection PubMed
description AIMS: Gp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2 in AF has not been demonstrated. Accordingly, we investigated whether myocardial NOX2 overexpression in mice (NOX2-Tg) is sufficient to generate a favourable substrate for AF and further assessed the effects of atorvastatin, an inhibitor of NOX2, on atrial superoxide production and AF susceptibility. METHODS AND RESULTS: NOX2-Tg mice showed a 2- to 2.5-fold higher atrial protein content of NOX2 compared with wild-type (WT) controls, which was associated with a significant (twofold) increase in NADPH-stimulated superoxide production (2-hydroxyethidium by HPLC) in left and right atrial tissue homogenates (P = 0.004 and P = 0.019, respectively). AF susceptibility assessed in vivo by transoesophageal atrial burst stimulation was modestly increased in NOX2-Tg compared with WT (probability of AF induction: 88% vs. 69%, respectively; P = 0.037), in the absence of significant alterations in AF duration, surface ECG parameters, and LV mass or function. Mechanistic studies did not support a role for NOX2 in promoting electrical or structural remodelling, as high-resolution optical mapping of atrial tissues showed no differences in action potential duration and conduction velocity between genotypes. In addition, we did not observe any genotype difference in markers of fibrosis and inflammation, including atrial collagen content and Col1a1, Il-1β, Il-6, and Mcp-1 mRNA. Similarly, NOX2 overexpression did not have consistent effects on RyR2 Ca(2+) leak nor did it affect PKA or CaMKII-mediated RyR2 phosphorylation. Finally, treatment with atorvastatin significantly inhibited atrial superoxide production in NOX2-Tg but had no effect on AF induction in either genotype. CONCLUSION: Together, these data indicate that while atrial NOX2 overexpression may contribute to atrial arrhythmogenesis, NOX2-derived superoxide production does not affect the electrical and structural properties of the atrial myocardium.
format Online
Article
Text
id pubmed-8479801
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84798012021-09-30 Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice Mighiu, Alexandra S Recalde, Alice Ziberna, Klemen Carnicer, Ricardo Tomek, Jakub Bub, Gil Brewer, Alison C Verheule, Sander Shah, Ajay M Simon, Jillian N Casadei, Barbara Cardiovasc Res Original Articles AIMS: Gp91-containing NADPH oxidases (NOX2) are a significant source of myocardial superoxide production. An increase in NOX2 activity accompanies atrial fibrillation (AF) induction and electrical remodelling in animal models and predicts incident AF in humans; however, a direct causal role for NOX2 in AF has not been demonstrated. Accordingly, we investigated whether myocardial NOX2 overexpression in mice (NOX2-Tg) is sufficient to generate a favourable substrate for AF and further assessed the effects of atorvastatin, an inhibitor of NOX2, on atrial superoxide production and AF susceptibility. METHODS AND RESULTS: NOX2-Tg mice showed a 2- to 2.5-fold higher atrial protein content of NOX2 compared with wild-type (WT) controls, which was associated with a significant (twofold) increase in NADPH-stimulated superoxide production (2-hydroxyethidium by HPLC) in left and right atrial tissue homogenates (P = 0.004 and P = 0.019, respectively). AF susceptibility assessed in vivo by transoesophageal atrial burst stimulation was modestly increased in NOX2-Tg compared with WT (probability of AF induction: 88% vs. 69%, respectively; P = 0.037), in the absence of significant alterations in AF duration, surface ECG parameters, and LV mass or function. Mechanistic studies did not support a role for NOX2 in promoting electrical or structural remodelling, as high-resolution optical mapping of atrial tissues showed no differences in action potential duration and conduction velocity between genotypes. In addition, we did not observe any genotype difference in markers of fibrosis and inflammation, including atrial collagen content and Col1a1, Il-1β, Il-6, and Mcp-1 mRNA. Similarly, NOX2 overexpression did not have consistent effects on RyR2 Ca(2+) leak nor did it affect PKA or CaMKII-mediated RyR2 phosphorylation. Finally, treatment with atorvastatin significantly inhibited atrial superoxide production in NOX2-Tg but had no effect on AF induction in either genotype. CONCLUSION: Together, these data indicate that while atrial NOX2 overexpression may contribute to atrial arrhythmogenesis, NOX2-derived superoxide production does not affect the electrical and structural properties of the atrial myocardium. Oxford University Press 2021-01-23 /pmc/articles/PMC8479801/ /pubmed/33483749 http://dx.doi.org/10.1093/cvr/cvab019 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Mighiu, Alexandra S
Recalde, Alice
Ziberna, Klemen
Carnicer, Ricardo
Tomek, Jakub
Bub, Gil
Brewer, Alison C
Verheule, Sander
Shah, Ajay M
Simon, Jillian N
Casadei, Barbara
Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
title Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
title_full Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
title_fullStr Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
title_full_unstemmed Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
title_short Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
title_sort inducibility, but not stability, of atrial fibrillation is increased by nox2 overexpression in mice
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479801/
https://www.ncbi.nlm.nih.gov/pubmed/33483749
http://dx.doi.org/10.1093/cvr/cvab019
work_keys_str_mv AT mighiualexandras inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT recaldealice inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT zibernaklemen inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT carnicerricardo inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT tomekjakub inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT bubgil inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT breweralisonc inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT verheulesander inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT shahajaym inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT simonjilliann inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice
AT casadeibarbara inducibilitybutnotstabilityofatrialfibrillationisincreasedbynox2overexpressioninmice